Related references
Note: Only part of the references are listed.MyD88/IL1R Axis Regulates PD-1 Expression on Tumor-Associated Macrophages and Sustains Their Immunosuppressive Function in Melanoma
Sarang Tartey et al.
CANCER RESEARCH (2021)
Oleandrin sensitizes human osteosarcoma cells to cisplatin by preventing degradation of the copper transporter 1
Lei Yong et al.
PHYTOTHERAPY RESEARCH (2019)
The Interaction Between Two Worlds: MicroRNAs and Toll-Like Receptors
Recep Bayraktar et al.
FRONTIERS IN IMMUNOLOGY (2019)
Circadian sensitivity to the cardiac glycoside oleandrin is associated with diurnal intestinal P-glycoprotein expression
Cui Zhou et al.
BIOCHEMICAL PHARMACOLOGY (2019)
The Glycoside Oleandrin Reduces Glioma Growth with Direct and Indirect Effects on Tumor Cells
Stefano Garofalo et al.
JOURNAL OF NEUROSCIENCE (2017)
Identification of microRNAs associated with invasive and aggressive phenotype in cutaneous melanoma by next-generation sequencing
Sankhiros Babapoor et al.
LABORATORY INVESTIGATION (2017)
The cardiac glycoside oleandrin induces apoptosis in human colon cancer cells via the mitochondrial pathway
Li Pan et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
miR-146a Exerts Differential Effects on Melanoma Growth and Metastatization
Monica Raimo et al.
MOLECULAR CANCER RESEARCH (2016)
Oleandrin induces DNA damage responses in cancer cells by suppressing the expression of Rad51
Zhengqiang Bao et al.
ONCOTARGET (2016)
Assessment of the anticancer mechanism of ferulic acid via cell cycle and apoptotic pathways in human prostate cancer cell lines
Canan Eroglu et al.
TUMOR BIOLOGY (2015)
Editorial: Pattern recognition receptors and cancer
Anton G. Kutikhin et al.
FRONTIERS IN IMMUNOLOGY (2015)
PBI-05204, a supercritical CO2 extract of Nerium oleander, inhibits growth of human pancreatic cancer via targeting the PI3K/mTOR pathway
Yong Pan et al.
INVESTIGATIONAL NEW DRUGS (2015)
BDNF Mediates Neuroprotection against Oxygen-Glucose Deprivation by the Cardiac Glycoside Oleandrin
Michael J. Van Kanegan et al.
JOURNAL OF NEUROSCIENCE (2014)
miR-146a promotes the initiation and progression of melanoma by activating Notch signaling
Matteo Forloni et al.
ELIFE (2014)
Toll-like receptor signaling pathways
Takumi Kawasaki et al.
FRONTIERS IN IMMUNOLOGY (2014)
Molecular Pathways: Toll-like Receptors in the Tumor Microenvironment-Poor Prognosis or New Therapeutic Opportunity
Lisa A. Ridnour et al.
CLINICAL CANCER RESEARCH (2013)
Nerium oleander derived cardiac glycoside oleandrin is a novel inhibitor of HIV infectivity
Shailbala Singh et al.
FITOTERAPIA (2013)
Augmentation of Therapeutic Responses in Melanoma by Inhibition of IRAK-1,-4
Ratika Srivastava et al.
CANCER RESEARCH (2012)
Toll-Like Receptor Transcriptome in the HPV-Positive Cervical Cancer Microenvironment
Correne A. DeCarlo et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
Pathogen Recognition by the Innate Immune System
Himanshu Kumar et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2011)
The Structural Biology of Toll-like Receptors
Istvan Botos et al.
STRUCTURE (2011)
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Taro Kawai et al.
NATURE IMMUNOLOGY (2010)
Cytotoxic Effects of Cardiac Glycosides in Colon Cancer Cells, Alone and in Combination with Standard Chemotherapeutic Drugs
Jenny Felth et al.
JOURNAL OF NATURAL PRODUCTS (2009)
Oleandrin-mediated inhibition of human tumor cell proliferation: importance of Na,K-ATPase α subunits as drug targets
Peiying Yang et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Cancers take their Toll - the function and regulation of Toll-like receptors in cancer cells
R. Chen et al.
ONCOGENE (2008)
Toll-like receptor 3 expressed by melanoma cells as a target for therapy?
Bruno Salaun et al.
CLINICAL CANCER RESEARCH (2007)
Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro
Joanna M. Ilvesaro et al.
PROSTATE (2007)
Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5
S Frese et al.
CANCER RESEARCH (2006)
TLR3 can directly trigger apoptosis in human cancer cells
Bruno Salaun et al.
JOURNAL OF IMMUNOLOGY (2006)
Inflammation-associated cancer:: NF-κB is the lynchpin
QT Li et al.
TRENDS IN IMMUNOLOGY (2005)
Nuclear factor-κB inhibitors as sensitizers to anticancer drugs
C Nakanishi et al.
NATURE REVIEWS CANCER (2005)
Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion markers in CD-1 mouse skin by oleandrin
F Afaq et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2004)
A screen for drugs that protect against the cytotoxicity of polyglutamine-expanded androgen receptor
F Piccioni et al.
HUMAN MOLECULAR GENETICS (2004)
Induction of cyclooxygenase-2 overexpression in human gastric epithelial cells by Helicobacter pylori involves TLR2/TLR9 and c-Src-dependent nuclear factor-κB activation
YJ Chang et al.
MOLECULAR PHARMACOLOGY (2004)
Bacterial lipopolysaccharide induces transforming growth factor β and hepatocyte growth factor through toll-like receptor 2 in cultured human colon cancer cells
T Yoshioka et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2001)
LC/MS/MS analyses of an oleander extract for cancer treatment
XM Wang et al.
ANALYTICAL CHEMISTRY (2000)
Anvinel™, an extract of Nerium oleander, induces cell death in human but not murine cancer cells
S Pathak et al.
ANTI-CANCER DRUGS (2000)
Share Paper
